We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
You may need to tell DVLA if you have cardiac problems - download the correct form if you need to let them know
This is a summary of the evidence on new cardiac technologies.
Anti-cancer therapy with carfilzomib has been associated with cases of cardiac arrest, cardiac failure, and myocardial infarction, including in patients without pre-existing cardiac disorders.…
There have been reports of severe, sometimes fatal, cases of cardiac failure in patients treated with crizotinib.
Fingolimod can cause persistent bradycardia, which can increase the risk of serious cardiac arrhythmias. New contraindications have been introduced for patients with pre-existing cardiac disorders.…
You may need to send DVLA a form if you've had a heart attack (myocardial infarction) or heart, cardiac or coronary angioplasty.…
Patients receiving apomorphine and domperidone require an assessment of cardiac risk factors and ECG monitoring to reduce the risk of serious arrhythmia related to QT-prolongation.
Prescribing information has been updated to help to minimise the risk of serious adverse reactions in patients with cardiac disease.
Recommendations on leadless cardiac pacemaker therapy from MHRA Expert Advisory Group…
There have been reports of cardiac events including QT prolongation, torsades de pointes, and cardiac arrest in patients who have taken high or very high doses of loperamide as a drug of abuse or for self-treatment of opioid withdrawal.…
Recent epidemiological evidence suggests a possible small increased risk of congenital cardiac defects in association with fluoxetine in early pregnancy, similar to that seen with paroxetine.…
…Erythromycin has been associated with events secondary to QT interval prolongation such as cardiac arrest and ventricular fibrillation.…
(All manufacturers) Low risk of Mycobacterium infection in patients undergoing cardiac surgery, associated with heater-coolers used with cardiopulmonary bypass machines. Possible cause may be Mycobacterium-contaminated water in the heater-coolers (MDA/2015/022)
Proposed changes to the cardiac monitoring unit and acute medical services in Bridlington, North Yorkshire.
Indication restricted to nausea and vomiting, new contraindications, and reduced dose and duration of use.
If pioglitazone is used in combination with insulin patients should be observed for signs and symptoms of heart failure, weight gain, and oedema.
Check if you need to tell DVLA about a health or medical condition, how to report medical conditions to DVLA
New monitoring instructions to detect these side effects as soon as possible.
Manufactured by Medtronic – battery voltage may reduce to a point where the device is no longer able to provide patient pacing therapy - MDA/2015/038
Mirabegron is now contraindicated in patients with severe uncontrolled hypertension; advice about regular monitoring is being introduced because of cases of severe hypertension.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).